scPharmaceuticals Inc. Annual Operating Income (Loss) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
scPharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2023.
  • scPharmaceuticals Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$14.4M, a 4.98% decline year-over-year.
  • scPharmaceuticals Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$60.4M, a 34.8% decline year-over-year.
  • scPharmaceuticals Inc. annual Operating Income (Loss) for 2023 was -$55.4M, a 53.2% decline from 2022.
  • scPharmaceuticals Inc. annual Operating Income (Loss) for 2022 was -$36.2M, a 40% decline from 2021.
  • scPharmaceuticals Inc. annual Operating Income (Loss) for 2021 was -$25.8M, a 13.7% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$55.4M -$19.2M -53.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 -$36.2M -$10.3M -40% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 -$25.8M +$4.11M +13.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 -$29.9M +$2.97M +9.03% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-22
2019 -$32.9M -$3.24M -10.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-23
2018 -$29.7M -$6.23M -26.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-24
2017 -$23.4M -$5.53M -30.9% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-21
2016 -$17.9M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.